Archive for the 'Asbestos & Mesothelioma Studies' Category

Asbestos & Mesothelioma Studies news feed.

ONCOS-102 Passes Safety Evaluation in Phase I Clinical Trials, Phase II Clinical Trial Recommended

A new immunotherapy developed by Targovax has recently passed Phase I clinical trials and is set to begin Phase II evaluation of this new treatment that may help those suffering from mesothelioma. ONCOS-102 was used in separate Phase I clinical trials; one in combination with chemotherapy, and one with immunotherapy. Cisplatin and pemetrexed are two

more

Legitimate Data and Research is Required for Treatment Approval

For cancer patients who have little success with traditional chemotherapy and radiation treatments, immunotherapy treatments are becoming known alternatives – working with the body’s own immune system to become stronger and better able to fight cancer cells and other infections. A mesothelioma diagnosis is often grim, with survival rates at approximately one year at diagnosis.

more

Pleural Catheter vs. Pleurodesis

Symptoms for pleural mesothelioma are typically centered on lung function breathing, with shortness of breath (dyspnea), pleural effusion (fluid build-up), and pain in the chest being the primary indicators.  There is no cure for malignant pleural mesothelioma and while scientists and researchers are continually developing new treatments and therapies, in the meantime, advancements in palliative

more

Smoking Plus Asbestos Exposure – A Deadly Combination

In 2004, the American Thoracic Society called asbestos “the largest cause of occupational cancer in the United States and a significant cause of disease and disability from nonmalignant disease.” Asbestos is a known carcinogen. It has been found to be the cause of many different cancers in those who were exposed to the popular building

more

Autophagy Inhibitors Potentially Make Chemotherapy More Effective in Mesothelioma Patients

Autophagy is a natural and regulated self-degradative process in cells that plays a critical role in balancing sources of energy and removing aggravated proteins, damaged organelles, and pathogens. During autophagy, cells break down and recycle their different parts in order to make new cells. In mesothelioma, autophagy is necessary for mesothelial cell growth. A recent

more

November is Lung Cancer Awareness Month

The National Cancer Institute places lung cancer as the leading cause of death from cancer in the United States. One out of every four cancer deaths is attributable to lung cancer, and in 2016 alone The America Cancer Society an estimated 158,080 people passed away from this disease. Lung cancer begins in the lungs when

more

Palliative Care for Mesothelioma Patients

What is Palliative Care? For serious illnesses, some patients may receive palliative care, or palliative treatment. Palliative care treats the symptoms of the disease, not the disease itself, in an attempt to provide relief and make the patient as comfortable as possible during their illness. Palliative treatment can be provided at the beginning of treatment,

more

Misconceptions about Mesothelioma

Mesothelioma is lung cancer One of the most common areas of the body where mesothelioma develops is the lung, and because of this, many misunderstand mesothelioma to be a type of lung cancer. In actuality, mesothelioma is cancer of the mesothelium – found in the lining of the heart, lungs, abdomen, or internal reproductive organs.

more

Pleurectomy and Decortication Improve Survival, but May Impact Quality Of Life

Pleurectomy and Decortication (P/D) is a two-part surgical procedure that removes the pleural lining around the lungs (pleurectomy) and tumors along the surface area of the lung (decortication). To qualify for this surgery, mesothelioma patients must be in overall good health, and in the early stages of the disease. Since mesothelioma is an aggressive cancer

more

The Effectiveness of Cisplatin and Pemetrexed in Pericardial Mesothelioma

Out of all the types of mesothelioma, pericardial mesothelioma is one of the rarest forms, accounting for only 0.002% of all known diagnosed mesothelioma cases. Mesothelioma is caused by asbestos exposure, and despite this knowledge and years of research, scientists and researchers still do not have a clear answer as to how the asbestos fibers

more

Amosite vs. Chrysotile Asbestos in Peritoneal Mesothelioma

Mesothelioma is rare and aggressive asbestos-caused cancer in which there is no cure. The cancer affects the lining that surrounds various organs and cavities in the body; most tumors are commonly found in the lining of lungs and the chest (the pleura), making up two thirds of all diagnosed cases.  Peritoneal mesothelioma, sometimes referred to

more

Opdivo, Yervoy, and Keytruda: Immunotherapy Options for Mesothelioma

Immunotherapy treatments are becoming known alternatives to chemotherapy in cancer patients who have had little success with traditional cancer treatments. With mesothelioma, often times first line treatments have little effect because the cancer is typically in the advanced stages by the time it is detected.  While there currently is no cure for mesothelioma, scientists and

more

Determining and Prolonging Survival Rates In Mesothelioma

The average survival rate for mesothelioma after diagnosis is less than one year; however, certain individuals will survive longer than others, but the reason as to why this is, is largely unknown.  The latest study to be published in Histopathology investigates what it is in the body that determines a higher survival rate in some,

more

Study: More Mesothelioma Diagnoses Are Discovered At Autopsy Than Clinically

A mesothelioma diagnosis often a grim one; fatality rates are high as there is no known cure. Treatment can help alleviate pain and symptoms, but more often than not, patients will succumb to this deadly asbestos-caused disease. While treatment has proven to be difficult, diagnosing mesothelioma and other asbestos-caused illnesses is often just as challenging.

more

Trimodality Therapy Increases Survival; Immunotherapy Treatment Approved by FDA

Since mesothelioma is often difficult to treat, scientists and researchers look to combination treatments and therapies to improve chances of patients’ survival. There is no “one” treatment that is used across the board in treating mesothelioma, because patients react differently, whether it is to chemotherapy, radiation therapy, immunotherapy, or surgery.  A research team from MD

more

Last update: March 06, 2014. 08:41:31 pm.